Overall, the predicted age in the PREVENT-AD cohort overestimated the chronological age by ~5 years (Fig. 3e), but APOE ε4 status was not associated with differences in this PAD (F1,253 < 1; p = 0.49, Table 3 and Fig. 3f). This evidence concerns the gene APOE and peripheral arterial disease.